Drug Shortage Report for TRAJENTA
| Report ID | 16543 |
| Drug Identification Number | 02370921 |
| Brand name | TRAJENTA |
| Common or Proper name | Trajenta |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | MARKETED |
| Active Ingredient(s) | LINAGLIPTIN |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30's |
| ATC code | A10BH |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-07-21 |
| Actual start date | |
| Estimated end date | 2017-07-31 |
| Actual end date | 2017-07-31 |
| Shortage status | Resolved |
| Updated date | 2017-08-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2017-08-01 | English | Compare |
| v5 | 2017-07-31 | French | Compare |
| v4 | 2017-07-31 | English | Compare |
| v3 | 2017-07-22 | English | Compare |
| v2 | 2017-07-20 | French | Compare |
| v1 | 2017-07-20 | English | Compare |
Showing 1 to 6 of 6